ONCOSEC MEDICAL INCORPORATED: 10-Q filed 2015-06-09
What ONCOSEC MEDICAL INCORPORATED reported in its quarterly report filed 2015-06-09 (fiscal Q3 2015): 22 published measures, 64 facts as tagged in accession 0001104659-15-044340.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2015-06-09
- Fiscal period
- fiscal Q3 2015
- Accession
- 0001104659-15-044340 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; a measure with a published history links to it, and the history shows the latest-filed value per period. All ONCOSEC MEDICAL INCORPORATED filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-04-30 | 27,643,279 | USD | |
| At 2014-07-31 | 39,391,609 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-04-30 | 1,755,124 | USD | |
| At 2014-07-31 | 1,323,551 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-04-30 | 25,888,155 | USD | |
| At 2014-07-31 | 38,068,058 | USD | |
| At 2014-04-30 | 24,522,189 | USD | |
| At 2013-07-31 | 4,739,124 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-04-30 | 25,439,188 | USD | |
| At 2014-07-31 | 37,852,694 | USD | |
| At 2014-04-30 | 24,252,154 | USD | |
| At 2013-07-31 | 4,970,175 | USD |
Capital expenditure payments
Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-08-01 to 2015-04-30 | 761,693 | USD | 273 |
| 2013-08-01 to 2014-04-30 | 154,105 | USD | 273 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-04-30 | -40,029,730 | USD | |
| At 2014-07-31 | -25,363,032 | USD |
Basic weighted-average shares
Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-02-01 to 2015-04-30 | 12,349,693 | shares | 89 |
| 2014-08-01 to 2015-04-30 | 12,347,450 | shares | 273 |
| 2014-02-01 to 2014-04-30 | 10,364,406 | shares | 89 |
| 2013-08-01 to 2014-04-30 | 8,789,111 | shares | 273 |
Diluted weighted-average shares
Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-02-01 to 2015-04-30 | 12,349,693 | shares | 89 |
| 2014-08-01 to 2015-04-30 | 12,347,450 | shares | 273 |
| 2014-02-01 to 2014-04-30 | 10,364,406 | shares | 89 |
| 2013-08-01 to 2014-04-30 | 8,789,111 | shares | 273 |
Basic earnings per share
Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-02-01 to 2015-04-30 | -0.48 | USD/shares | 89 |
| 2014-08-01 to 2015-04-30 | -1.19 | USD/shares | 273 |
| 2014-02-01 to 2014-04-30 | -0.37 | USD/shares | 89 |
| 2013-08-01 to 2014-04-30 | -0.96 | USD/shares | 273 |
Diluted earnings per share
Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-02-01 to 2015-04-30 | -0.48 | USD/shares | 89 |
| 2014-08-01 to 2015-04-30 | -1.19 | USD/shares | 273 |
| 2014-02-01 to 2014-04-30 | -0.37 | USD/shares | 89 |
| 2013-08-01 to 2014-04-30 | -0.96 | USD/shares | 273 |
Income tax expense or benefit
Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-02-01 to 2015-04-30 | 1,059 | USD | 89 |
| 2014-08-01 to 2015-04-30 | 1,969 | USD | 273 |
| 2014-02-01 to 2014-04-30 | 814 | USD | 89 |
| 2013-08-01 to 2014-04-30 | 41,773 | USD | 273 |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-04-30 | 1,201,338 | USD | |
| At 2014-07-31 | 581,054 | USD |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-02-01 to 2015-04-30 | -5,986,286 | USD | 89 |
| 2014-08-01 to 2015-04-30 | -14,664,729 | USD | 273 |
| 2014-02-01 to 2014-04-30 | -3,816,030 | USD | 89 |
| 2013-08-01 to 2014-04-30 | -8,406,303 | USD | 273 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-04-30 | 26,318,633 | USD | |
| At 2014-07-31 | 38,319,177 | USD |
Net finite-lived intangible assets
Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-07-31 | 464,693 | USD |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-04-30 | 12,351,763 | shares | |
| At 2014-07-31 | 12,231,554 | shares |
Additional paid-in capital
Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-04-30 | 58,760,949 | USD | |
| At 2014-07-31 | 56,081,475 | USD |
Other noncurrent assets
Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-04-30 | 123,308 | USD | |
| At 2014-07-31 | 26,685 | USD |
Prepaid expenses and other current assets
Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-04-30 | 879,445 | USD | |
| At 2014-07-31 | 466,483 | USD |
Net income available to common stockholders
Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-02-01 to 2015-04-30 | -5,987,345 | USD | 89 |
| 2014-08-01 to 2015-04-30 | -14,666,698 | USD | 273 |
| 2008-02-08 to 2015-04-30 | -40,000,000 | USD | 2639 |
| 2014-02-01 to 2014-04-30 | -3,816,844 | USD | 89 |
| 2013-08-01 to 2014-04-30 | -8,468,760 | USD | 273 |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-02-01 to 2015-04-30 | 2,053,964 | USD | 89 |
| 2014-08-01 to 2015-04-30 | 5,371,245 | USD | 273 |
| 2014-02-01 to 2014-04-30 | 2,115,374 | USD | 89 |
| 2013-08-01 to 2014-04-30 | 4,472,692 | USD | 273 |
Depreciation, depletion and amortization
Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-08-01 to 2015-04-30 | 601,777 | USD | 273 |
| 2013-08-01 to 2014-04-30 | 579,545 | USD | 273 |
Inspect the source
- Entity
- ONCOSEC MEDICAL INCORPORATED / CIK 0001444307
- Captured
- SEC response SHA-256
326bcab6a98b5e6098a865fe967c999ac8b3247d9466d112c5306da6df2f5607
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001444307.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))